...
首页> 外文期刊>Arzneimittel-Forschung: =Drug Research >Comparison of liquid chromatography-ultraviolet and chromatography-tandem mass spectrometry for the determination of indapamide in human whole blood and their applications in bioequivalence studies.
【24h】

Comparison of liquid chromatography-ultraviolet and chromatography-tandem mass spectrometry for the determination of indapamide in human whole blood and their applications in bioequivalence studies.

机译:液相色谱-紫外光谱法和色谱-串联质谱法测定人全血中吲达帕胺的比较及其在生物等效性研究中的应用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to compare two methods which were based on liquid chromatography with ultraviolet detection (LC-UV) and liquid chromatography-tandem mass spectrometry (LC-MS/MS), respectively, to determine indapamide (CAS 26807-65-8) and to apply them to bioequivalence studies. The universal parameters, including selectivity, linearity, precision, and quantification limit, served as gold standard for the comparison of the two methods. As a result, the two methods were both very consistent and reliable. Furthermore, the LC-MS/MS method required only one-fifth the blood volume needed by the other method and was approximately 25 times more sensitive than the other method. The total run time of the LC-MS/MS method was 3.5 min per sample as opposed to 11 min for the other method. Forty healthy male Chinese volunteers were selected as subjects. One half were orally administrered 2.5 mg indapamide immediate release tablets while the other half were orally administered 1.5 mg indapamide sus-tained release coated tablets. The collected blood samples were determined with the two methods described above. The pharmacokinetic parameters were determined using a noncompartmental method. For the bioequivalence studies, the pharmacokinetic parameters acquired here were in line with the literature and parameters met the criteria set by the State Food and Drug Administration of China (SFDA) for bioequivalence study, indicating that generic drugs are bioequivalent to branded drugs. The present study suggests that the two methods based on LC-UV and LC-MS/MS were suitable for bioavailability studies of indapamide with different pharmaceutical formulations. Consequently, it can be believed that the criterion that each individual expected concentration range would need a given bioassay with the requested sensitivity is not absolutely right. In practice, most of the time, the highest sensitivity allows to bioassay concentrations in a higher range.
机译:这项研究的目的是比较两种分别基于紫外检测液相色谱(LC-UV)和液相色谱-串联质谱(LC-MS / MS)的方法来测定吲达帕胺(CAS 26807-65- 8)并将其应用于生物等效性研究。通用参数,包括选择性,线性,精密度和定量限,是比较这两种方法的金标准。结果,这两种方法都非常一致且可靠。此外,LC-MS / MS方法仅需要另一种方法所需血量的五分之一,并且灵敏度是另一种方法的25倍左右。 LC-MS / MS方法的总运行时间为每个样品3.5分钟,而其他方法为11分钟。选择40名健康的中国男性志愿者作为受试者。一半口服2.5毫克吲达帕胺速释片,另一半口服1.5毫克吲达帕胺缓释包衣片。用上述两种方法测定采集的血样。使用非房室方法确定药代动力学参数。对于生物等效性研究,此处获得的药代动力学参数与文献一致,并且参数符合中国国家食品药品监督管理局(SFDA)为生物等效性研究设定的标准,表明仿制药与品牌药物具有生物等效性。本研究表明,基于LC-UV和LC-MS / MS的两种方法均适用于吲达帕胺与不同药物制剂的生物利用度研究。因此,可以认为,每个单独的预期浓度范围将需要具有所需灵敏度的给定生物测定的标准不是绝对正确的。实际上,在大多数情况下,最高灵敏度允许在更高范围内进行生物测定浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号